Skip to main content

Table 7 Detailed binding interactions of compounds with the protein with distances in (Ã…)

From: QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent

Compounds

Hydrogen bonds

Hydrophobic bonds

Electrostatic bonds

Others

π–π

Ï€-Alkyl

Alkyl

Ï€-Sigma

Ï€-Anion

Ï€-Sulfur

13

ASN 116 (3.35), ARG 127 (3.16)

PHE 103 (5.11)

TYR 112 (5.19),

ARG 120 (3.77),

ARG 484 (5.38)

–

THR 479 (3.35)

GLU 483 (4.03)

–

31

TYR 435 (3.37),

TYR 326 (5.30)

TYR 398 (5.31),

TYR 398 (3.74)

LEU 171 (4.92)

LEU 171 (3.37), ILE 199 (3.58)

–

CYS 172 (5.45), PHE 343 (5.70)

33

SER 59 (3.47), TYR 60 (3.47),

CYS 172 (3.67),

CYS 397 (2.93),

TYR 435 (3.07),

CYS 172 (3.27),

CYS 172 (3.26),

GLY 434 (3.51),

TYR 435 (3.12)

TRP 388 (5.12),

GLY 57 (3.58),

GLY 57 (4.03)

PHE 343 (5.44),

TYR 398 (5.39)

LYS 296 (4.94)

CYS 397 (4.39)

CYS 397 (4.34)

LEU 171 (5.41)

–

–

TYR 60 (4.98)

Eldepryl

(Reference)

GLN 206 (3.14)

–

TYR 398 (5.45),

TYR 435 (4.21)

–

–

–

–